Depression Clinical Trials in Baltimore, MD

Depression Clinical Trials in Baltimore, MD

View the best 10 depression medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Depression clinical trial.

Trials in Baltimore, Maryland

Here are the top 10 medical studies for depression in Baltimore, Maryland

Image of Clinical Site in Anaheim, United States.

Lumateperone

Behavioural Intervention

Recruiting1 awardPhase 3
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Image of University of Maryland School of Medicine in Baltimore, United States.

Aerobic exercise +1 More

Behavioural Intervention

Recruiting1 awardPhase 2
This trial tests a treatment combining duloxetine and aerobic exercise for adults with knee osteoarthritis and depression. Duloxetine helps manage pain and mood, making it easier for patients to stick to their exercise routine. Duloxetine, an anti-depressant medication, has been recently approved for managing knee osteoarthritis and has shown effectiveness in reducing pain and improving function in patients with osteoarthritis.
Image of University of Maryland Baltimore in Baltimore, United States.

Engagement Navigator Service

Behavioural Intervention

Recruiting1 award1 criteria
This trial will create a new support service to help people and families who are at high risk of not staying engaged in their care. They will involve participants, families, and staff in developing the service,
Image of Johns Hopkins Hospital / Johns Hopkins University in Baltimore, United States.

Transcranial Direct Current Stimulation

Device

Recruiting0 awards
This trial is studying whether a non-invasive brain stimulation technique can help improve non-motor symptoms in people with Parkinson's disease.
Image of Site 4082 in Oceanside, United States.

ALTO-203

Procedure

Recruiting0 awardsPhase 2
This trial aims to study the effects of ALTO-203 in patients with Major Depressive Disorder (MDD) through two treatment periods. In the first period, participants will receive a single dose of
Image of Johns Hopkins School of Nursing in Baltimore, United States.

PRIME Intervention

Behavioral Intervention

Recruiting1 award6 criteria
This trial aims to help older women with disabilities who experience chronic pain and depression. The intervention includes home visits and virtual group sessions to help participants reduce pain and improve mood.
Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Placebo +1 More

Pharmacotherapy

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Sheppard Pratt Health System in Baltimore, United States.

Psilocybin

Psychedelic

Recruiting1 awardPhase 3
This trial is testing a new medication called COMP360 to help people with severe depression that hasn't improved with other treatments. The study involves adults aged 18 and older. Researchers want to see if a single dose of COMP360 can reduce depression symptoms when given with psychological support.
Image of Johns Hopkins University School of Medicine in Baltimore, United States.

Psilocybin +1 More

Psychedelic Therapy

Recruiting1 awardPhase 1
This trial aims to understand how psilocybin affects chronic pain in patients with chronic low back pain and depression. Participants will receive either a high dose of psilocybin or methylphenidate
Image of Chicago Research Center in Chicago, United States.

Aticaprant

Recruiting1 awardPhase 3
This trial aims to see if aticaprant is effective in preventing the return of depression symptoms when added to antidepressant therapy in individuals with major depressive disorder who have already responded well to aticaprant treatment

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.